rvallee
Senior Member (Voting Rights)
There have been many similar polls, including from this person who has a PhD in pharmacy. They were pretty much all null and most had many negative reports. Mestinon seemed to be particularly disappointing. Almost all were busts, aside from antihistamines, IIRC.They look to me like well within the range of normal fluctuations, especially as it's a self selected sample with no information on length of treatment, what other treatments they are doing, length and severity of disease, and with much too small sample sizes to be statistically significant, no control group, no blinding, subjective outcomes etc. I suspect even CBT could show pretty graphs like this and would be equally misleading.
The person behind this account has been doing this for several months now. It's an iterative process that first asked about many supplements and drugs and is now refining to stratifying with doses. This is how investigative work is supposed to happen, it's just not happening in our case because no one is authorized to do it.
The patient population is trying those drugs and supplements. It's happening because of the void of expertise, might as well learn from it. I've already seen people trying regulated drugs buying from gray market pharmacies. Again, this is the void forcing people to work around the system, just like it was done with AIDS.
It should be formal and official. But the void is here.
It's basically certain that nattokinase is not going to be a solution, it's a data point for what it does, showing potential mechanisms of action in some people. In this case it's an enzyme that seems to break down blood clots. It's a clue, likely not a final clue. Maybe an adjacent clue. But damn this is how investigations are supposed to work, following evidence, building on itself. Seems like medical research can't do this anymore.